Attachment O. 6 General Electric Specifications
Attachment O. Demonstration Quality Strategy In order to assess and improve the quality of services delivered under this Demonstration, DCH will implement a rigorous quality strategy and evaluation process formally documented as the Demonstration Evaluation Design. This design or plan will be developed with assistance from Emory University, the independent contractor charged with evaluating the effectiveness of the Demonstration. The evaluation design must incorporate key goals, objectives and a set of performance measures that align well with the logical sequence through which the Demonstration can and will affect Provider’s and P4HB Participant’s behavior such that the key outcomes - longer inter partum intervals, lower low birth weight rates and cost savings - can be achieved. The evaluation design must receive final approval from CMS. Reporting to CMS will occur on a quarterly and annual basis with a final report due to CMS at the end of the Demonstration period. CMO reporting will be due on a quarterly and annual basis as identified below and in the CMS Special Terms and Conditions. The Evaluation Design will include: · Key Goals, Objectives and Performance Targets · Program Hypotheses · Performance Measures · Analysis pertaining to the achievement of the Performance Targets · Assessment of the rate at which the Demonstration was implemented · Assessment of the Demonstration Providers’ understanding of program eligibility, service coverage and payment rates across sites of care · Assessment of the Providers’ and P4HB Participants satisfaction with the Demonstration · Assessment of the per Demonstration year changes in family planning visits regardless of payer source, per poor and near poor women in Georgia · Determination of averted births among P4HB Participants and tests of budget neutrality · The relationship between the Demonstration implementation and changes in pregnancy and birth rates, low birth weight rate and inter-pregnancy interval for “targeted” versus control group women · The relationship between the Demonstration and changes in pregnancies, unintended births, intra-partum intervals and post-partum birth control use among “targeted” and control groups · The relationship of the Demonstration to changes in inter-pregnancy intervals, rate of repeat very low birth weight and preterm delivery rates Key Goals: If participation in the Demonstration penetrates the eligible population to the extent hoped for and P4HB Participants are consistent users of fami...
Attachment O. 4 Solar PV Canopy Specifications
Attachment O. Required Forms; and,
Attachment O. Indirect Cost Rate Letter as attached to this Amendment is hereby incorporated into the Contract, if applicable.
Attachment O. The rate formula set out in the Tariff, from Sheet No. 364 through 393, as may be amended from time to time.
Attachment O. In order to change the Attachment O rate formula, the governance and coordination provisions of Articles III and IV of this Appendix K shall apply, provided that those Owners that do not have their revenue requirements calculated through such formula shall not have voting rights pursuant to Articles III and IV of this Appendix K with respect to such a change.
Attachment O. Royalties Royalties means:
Attachment O. Financial Assurance Policy for Non-Participant FTR Customers ------------------------------------------------------------
Attachment O. SPECIAL REQUIREMENTS for GENZYME’S BELGIUM FACILITY [**] [**] = Portions of this exhibit have been omitted pursuant to a confidential treatment request. An unredacted version of this exhibit has been filed separately with the Commission.
